Degeneration of dopaminergic neurons induced by thrombin injection in the substantia nigra of the rat is enhanced by dexamethasone: Role of monoamine oxidase enzyme

NeuroToxicology

Volumn 31, Issue 1, 2010, Pages 55-66

  Argüelles, Sandro ^a,b   Herrera, Antonio J ^a,b   Carreño Müller, Eloisa ^a   de Pablos, Rocío M ^a,b   Villarán, Ruth F ^a   Espinosa Oliva, Ana M ^a   Machado, Alberto ^a,b   Cano, Josefina ^a,b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Dexamethasone; Dopaminergic neurodegeneration; Inflammation; Monoamine oxidase; Substantia nigra

Indexed keywords

ALPHA SYNUCLEIN; AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DEXAMETHASONE; MITOGEN ACTIVATED PROTEIN KINASE; THROMBIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME INHIBITION; FEMALE; MACROGLIA; MICROGLIA; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

ALPHA-SYNUCLEIN; ANALYSIS OF VARIANCE; ANIMALS; DEXAMETHASONE; DRUG SYNERGISM; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOIDS; HISTOCOMPATIBILITY ANTIGENS; HYDRAZINES; IN SITU NICK-END LABELING; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NERVE DEGENERATION; NEUROGLIA; NEURONS; NITRIC OXIDE SYNTHASE; ONCOGENE PROTEIN V-AKT; RATS; RATS, WISTAR; RECEPTORS, THROMBIN; SPECTROPHOTOMETRY; SUBSTANTIA NIGRA; SULFONAMIDES; THROMBIN; TIME FACTORS; TRANYLCYPROMINE; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; RATTUS;

EID: 74249104871     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.12.001     Document Type: Article

References (92)

1. 2+ concentration in gerbil hippocampus. J Cereb Blood Flow Metab 18 (1998) 274-280
2. Anderson D.C., and Cranford R.E. Corticosteroids in ischemic stroke. Stroke 10 (1979) 68-71
3. Baker A.F., Briehl M.M., Dorr R., and Powis P. Decreased antioxidant defence and increased oxidant stress during dexamethasone-induced apoptosis: bcl-2 prevents the loss of antioxidant enzyme activity. Cell Death Diff 3 (1996) 207-213
4. Beilin O., Karussis D.M., Korczyn A.D., Gurwitz D., Aronovich R., Hantai D., et al. Increased thrombin inhibition in experimental autoimmune encephalomyelitis. J Neurosci Res 79 (2005) 351-359
5. Bennett M.C., Milady G.W., Fleshner M., and Rose G.M. Synergy between chronic corticosterone and sodium azide treatments in producing a spatial learning deficit and inhibiting cytochrome oxidase activity. Proc Natl Acad Sci USA 93 (1996) 1330-1334
6. Bianchi P., Seguelas M.H., Parini A., and Cambon C. Activation of pro-apoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases. J Am Soc Nephrol 14 (2003) 855-862
7. Bobadilla N.A., Tapia E., Jiménez F., Sánchez-Lozada L.G., Santamaría J., Monjardín A., et al. Dexamethasone increases eNOS gene expression and prevents renal vasoconstriction induced by cyclosporine. Am J Physiol 277 Renal Physiol. 46 (1999) F464-F471
8. Bracken M.B., Shepard M.J., Collins W.F., Holford T.R., Young W., Baskin D.S., et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the second national acute spinal cord injury study. N Engl J Med 322 (1990) 1405-1411
9. Brazil D.P., and Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 26 (2001) 657-664
10. Burke R.E. Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: two approaches with therapeutic potential in the treatment of neurodegenerative disease. Pharmacol Ther 114 (2007) 261-277
11. Carlo P., Violani E., Del Rio M., Olasmaa M., Santagati S., Maggi A., et al. Monoamine oxidase B expression is selectively regulated by dexamethasone in cultured rat astrocytes. Brain Res 711 (1996) 175-183
12. Carreño-Müller E., Herrera A.J., de Pablos R.M., Tomás-Camardiel M., Venero J.L., Cano J., et al. Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia. J Neurochem 84 (2003) 1201-1214
13. Castaño A., Herrera A.J., Cano J., and Machado A. Effects of a short period of vitamin E-deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat. Neuroscience 53 (1993) 179-185
14. Castaño A., Herrera A.J., Cano J., and Machado A. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J Neurochem 70 (1998) 1584-1592
15. Castaño A., Herrera A.J., Cano J., and Machado A. The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. J Neurochem 81 (2002) 150-157
16. Chen J., Adachi N., Tsubota S., Nagaro T., and Arai T. Dexamethasone augments ischemia-induced extracellular accumulation of glutamate in gerbil hippocampus. Eur J Pharmacol 347 (1998) 67-70
17. Choi S.H., Joe E.H., Kim S.U., and Jin B.K. Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J Neurosci 23 (2003) 5877-5886
18. Choi S.H., Lee D.Y., Ryu J.K., Kim J., Joe E.H., and Jin B.K. Thrombin induces nigral dopaminergic neurodegeneration in vivo by altering expression of death-related proteins. Neurobiol Dis 14 (2003) 181-193
19. Chrysis D., Zaman F., Chagin A.S., Takigawa M., and Savendahl L. Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-phosphatidylinositol 3′-kinase signaling pathway. Endocrinology 146 (2005) 1391-1397
20. Cohen G., Farooqui R., and Kesler N. Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc Natl Acad Sci USA 94 (1997) 4890-4894
21. de Pablos R.M., Herrera A.J., Villarán R.F., Cano J., and Machado A. Dopamine-dependent neurotoxicity of lipopolysaccharide in substantia nigra. FASEB J 19 (2005) 407-409
22. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., and Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7 (1993) 75-83
23. Frackowiak J., Wisniewski H.M., Wegiel J., Merz G.S., Iqbal K., and Wang K.C. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. Acta Neuropathol 84 (1992) 225-233
24. Fryer H.J., Davis G.E., Manthorpe M., and Varon S. Lowry protein assay using an automatic microtiter plate spectrophotometer. Anal Biochem 153 (1986) 262-266
25. Gavrieli Y., Sherman Y., and Ben-Sasson S.A. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 119 (1992) 493-501
26. Giasson B.I., and Lee V.M. Parkin and the molecular pathways of Parkinson's disease. Neuron 31 (2001) 885-888
27. Gingrich M.B., and Traynelis S.F. Serine proteases and brain damage-is there a link?. Trends Neurosci 23 (2000) 399-407
28. Gloor S., Odink K., Guenther J., Nick H., and Monard D. A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins. Cell 47 (1986) 687-693
29. Guenther J., Nick H., and Monard D. A glia-derived neurite promoting factor with protease inhibitory activity. EMBO J 4 (1985) 1963-1966
30. Harris-White M.E., Chu T., Miller S.A., Simmons M., Teter B., Nash D., et al. Estrogen (E2) and glucocorticoid (Gc) effects on microglia and A beta clearance in vitro and in vivo. Neurochem Int 39 (2001) 435-448
31. Herrera A.J., Castaño A., Venero J.L., Cano J., and Machado A. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol Dis 7 (2000) 429-447
32. Herrera A.J., de Pablos R.M., Carreño-Müller E., Villarán R.F., Venero J.L., Tomás-Camardiel M., et al. The intrastriatal injection of thrombin in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through synaptic elimination. J Neurochem 105 (2008) 750-762
33. Hirsch E.C. Glial cells and Parkinson's disease. J Neurol 247 (2000) II58-II62
34. Huang C.F., Li G., Ma R., Sun S.G., and Chen J.G. Thrombin-induced microglial activation contributes to the degeneration of nigral dopaminergic neurons in vivo. Neurosci Bull 24 (2008) 66-72
35. Hunot S., Dugas N., Faucheux B., Hartmann A., Tardieu M., Debre P., et al. FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci 19 (1999) 3440-3447
36. 2 in vitro. Brain Res 671 (1995) 181-186
37. Iuchi T., Akaike M., Mitsui T., Ohshima Y., Shintani Y., Azuma H., et al. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92 (2003) 81-87
38. Kim K.Y., Kim M.Y., Choi H.S., Jin B.K., Kim S.U., and Lee Y.B. Thrombin induces IL-10 production in microglia as a negative feedback regulator of TNF-[alpha] release. Neuroreport 13 (2002) 849-852
39. Kim W.G., Mohney R.P., Wilson B., Jeohn G.H., Liu B., and Hong J.S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20 (2000) 6309-6316
40. Knauer D.J., Majumdar D., and Fong P.C. J Biol Chem 275 (2000) 37340-37346
41. Kunduzova O.R., Bianchi P., Pizzinat N., Escourrou G., Seguelas M.H., Parini A., et al. Regulation of JNK/ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. FASEB J 16 (2002) 1129-1131
42. Le W., Rowe D., Xie W., Ortiz I., He Y., and Appel S.H. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J Neurosci 21 (2001) 8447-8455
43. Leis H., Page A., Ramirez A., Bravo A., Segrelles C., Paramio J., et al. Glucocorticoid receptor counteracts tumorigenic activity of akt in skin through interference with the phosphatidylinositol 3-kinase signaling pathway. Mol Endocrinol 18 (2004) 303-311
44. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186 (1990) 464-485
45. Malorni W., Giammarioli A.M., Matarrese P., Pietrangeli P., Agostinelli E., Ciaccio A., et al. Protection against apoptosis by monoamine oxidase A inhibitors. FEBS Lett 426 (1998) 155-159
46. Manning B.D., and Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 129 (2007) 1261-1274
47. Manoli I., Le H., Alesci S., McFann K.K., Su Y.A., Kino T., et al. Monoamine oxidase-A is a major target gene for glucocorticoids in human skeletal muscle cells. FASEB J 19 (2005) 1359-1361
48. Maurel A., Hernandez C., Kunduzova O., Bompart G., Cambon C., Parini A., et al. Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats. Am J Physiol Heart Circ Physiol 284 (2003) H1460-H1467
49. McGeer E.G., Klegeris A., and McGeer P.L. Inflammation, the complement system and the diseases of aging. Neurobiol Aging 26 (2005) 94-97
50. McIntosh M.K., Pan J.-S., and Berdanier C.D. In vitro studies on the effects of dehydroepiandrosterone and corticosterone on hepatic steroid receptor binding and mitochondrial respiration. Comp Biochem Physiol 104A (1993) 147-153
51. McNamara C.A., Sarembock I.J., Gimple L.W., Fenton II J.W., Coughlin S.R., and Owens G.K. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 91 (1993) 94-98
52. Meins M., Piosik P., Schaeren-Wiemers N., Franzoni S., Troncoso E., Kiss J.Z., et al. Progressive neuronal and motor dysfunction in mice overexpressing the serine protease inhibitor protease nexin-1 in postmitotic neurons. J Neurosci 21 (2001) 8830-8841
53. Minghetti L., Nicolini A., Polazzi E., Greco A., Perretti M., Parente L., et al. Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. Br J Pharmacol 126 (1999) 1307-1314
54. Mitsui T., Azuma H., Nagasawa M., Iuchi T., Akaike M., Odomi M., et al. Chronic corticosteroid administration causes mitochondrial dysfunction in skeletal muscle. J Neurol 249 (2002) 1004-1009
55. Mitsuyo T., Adachi N., Yorozuya T., Tabo E., Nagaro T., and Arai T. Facilitation of ischemia-induced release of dopamine and neuronal damage by dexamethasone in the rat striatum. Eur J Pharmacol 465 (2003) 267-274
56. Möller T., Hanisch U.K., and Ransom B.R. Thrombin-induced activation of cultured rodent microglia. J Neurochem 75 (2000) 1539-1547
57. Möller T., Weinstein J.R., and Hanisch U.K. Activation of microglial cells by thrombin: past, present, and future. Semin Thromb Hemost 32 (2006) 69-76
58. Norris J.W., and Hachinski V.C. High dose steroid treatment in cerebral infarction. Br Med J (Clin Res Ed) 292 (1986) 21-23
59. Orzechowski A., Grizard J., Jank M., Gajkowska B., Lokociejewska M., Zaron-Teperek M., et al. Dexamethasone-mediated regulation of death and differentiation of muscle cells. Is hydrogen peroxide involved in the process?. Reprod Nutr Dev 42 (2002) 197-216
60. Orzechowski A., Jank M., Gajkowska B., Sadkowski T., Godlewski M.M., and Ostaszewski P. Delineation of signalling pathway leading to antioxidant-dependent inhibition of dexamethasone-mediated muscle cell death. J Muscle Res Cell Motil 24 (2003) 33-53
61. Oshima Y., Kuroda Y., Kunishige M., Matsumoto T., and Mitsui T. Oxidative stress-associated mitochondrial dysfunction in corticosteroid-treated muscle cells. Muscle Nerve 30 (2004) 49-54
62. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 2nd ed. (1986), Academic Press, San Diego
63. Poungvarin N., Bhoopat W., Viriyavejakul A., Rodprasert P., Buranasiri P., Sukondhabhant S., et al. Effects of dexamethasone in primary supratentorial intracerebral haemorrhage. N Engl J Med 316 (1987) 1229-1233
64. Reinhard E., Suidan H.S., Pavlik A., and Monard D. Glia-derived nexin/protease nexin-1 is expressed by a subset of neurons in the rat brain. J Neurosci Res 37 (1994) 256-270
65. Ribeiro M.C., Badaut J., Price M., Meins M., Bogousslavsky J., Monard D., et al. Thrombin in ischemic neuronal death. Exp Neurol 198 (2006) 199-203
66. Rieger J., Stander M., Loschmann P.A., Heneka M., Dichgans J., Klockgether T., et al. Synthesis and biological effects of NO in malignant glioma cells: modulation by cytokines including CD95L and TGF-beta, dexamethasone, and p53 gene transfer. Oncogene 17 (1998) 2323-2332
67. Ries V., Henchcliffe C., Kareva T., Rzhetskaya M., Bland R., During M.J., et al. Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease. Proc Natl Acad Sci USA 103 (2006) 18757-18762
68. Ruigrok Y.M., Dekkers P.J.W., Bromberg J.E.C., Algra A., and Rinkel G.J.E. Corticosteroid use and risk of aneurismal subarachnoid haemorrhage. J Neurol 253 (2006) 496-499
69. Ryu J., Pyo H., Jou I., and Joe E. Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-kappa B. J Biol Chem 275 (2000) 29955-29959
70. Santambrogio S., Martinotti R., Sardella F., Porro F., and Randazzo A. Is there a real treatment for stroke? Clinical and statistical comparison of different treatments in 300 patients. Stroke 9 (1978) 130-132
71. Seymour C.B., Mothersill C., Mooney R., Moriarty M., and Tipton K.F. Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity. Br J Cancer 89 (2003) 1979-1986
72. Shinoda J., Mclaughlin K.E., Swaroop G.R., Yamaguchi S.-I., Holmes M.C., and Whittle I.E. Molecular mechanisms underlying dexamethasone inhibition of inos expression and activity in c6 glioma cells. Glia 42 (2003) 68-76
73. Simmons M.L., and Murphy S. Cytokine regulate l-arginine-dependent cyclic GMP production in rat glial cells. Eur J Neurosci 5 (1993) 825-831
74. Singleton J.R., Baker B.L., and Thorburn A. Dexamethasone inhibits insulin-like growth factor signaling and potentiates myoblast apoptosis. Endocrinology 141 (2000) 2945-2950
75. Smith-Swintosky V.L., Zimmer S., Fenton J.W., and Mattson II M.P. Protease nexin-1 and thrombin modulate neuronal Ca2+ homeostasis and sensitivity to glucose deprivation-induced injury. J Neurosci 15 (1995) 5840-5850
76. Suo Z., Wu M., Ameenuddin S., Anderson H.E., Zoloty J.E., Citron B.A., et al. Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J Neurochem 80 (2002) 655-666
77. Suo Z., Wu M., Citron B.A., Gao C., and Festoff B.W. Persistent protease-activated receptor 4 signaling mediates thrombin-induced microglial activation. J Biol Chem 278 (2003) 37681-37689
78. Tanaka J., Fujita H., Matsuda S., Toku K., Sakanaka M., and Maeda N. Glucocorticoid- and mineralocorticoid receptors in microglial cells: the two receptors mediate differential effects of corticosteroids. Glia 20 (1997) 23-37
79. Tawara Y., Kagaya A., Uchitomi Y., Horiguchi J., and Yamawaki S. Lipopolysaccharide regulates both serotonin- and thrombin-induced intracellular calcium mobilization in rat C6 glioma cells: possible involvement of nitric oxide synthase-mediated pathway. J Neurosci Res 51 (1998) 517-525
80. Tazik S., Johnson S., Lu D., Johnson C., Youdim M.B., Stockmeier C.A., et al. Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis. Neurotox Res 15 (2009) 284-290
81. Tellez H., and Bauer R.B. Dexamethasone as treatment in acute cerebrovascular disease. 1. A controlled study in intracerebral haemorrhage. Stroke 4 (1973) 541-546
82. Tomás-Camardiel M., Rite I., Herrera Aj, de Pablos R.M., Cano J., Machado A., and Venero J.L. Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxinitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Neurobiol Dis 16 (2004) 190-201
83. Ubl J.J., Vöhringer C., and Reiser G. Co-existence of two types of [Ca2+]I-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells. Neuroscience 86 (1998) 597-609
84. Vaughan P.J., Pike C.J., Cotman C.W., and Cunningham D.D. Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci 15 (1995) 5389-5401
85. Vignos P.J., and Greene R. Oxidative respiration of skeletal muscle in experimental corticosteroid myopathy. J Lab Clin Med 81 (1973) 365-378
86. Vila M., Jackson-Lewis V., Guegan C., Wu D.C., Teismann P., Choi D.K., et al. The role of glial cells in Parkinson's disease. Curr Opin Neurol 14 (2001) 483-489
87. Walker G., Pfeilschifter J., and Kunz D. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone: evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. J Biol Chem 272 (1997) 16679-16687
88. Wang H., Ubl J.J., and Reiser G. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signalling. Glia 37 (2002) 53-63
89. Wang H., Ubl J.J., Stricker R., and Reiser G. Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am J Physiol: Cell Physiol 283 (2002) C1351-C1364
90. Weinstein J.R., Gold S.J., Cunningham D.D., and Gall C.M. Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci 15 (1995) 2906-2919
91. Yang Y.H., Hutchinson P., Santos L.L., and Morand E.F. Glucocorticoid inhibition of adjuvant arthritis synovial macrophage nitric oxide production: role of lipocortin 1. Clin Exp Immunol 111 (1998) 117-122
92. Youdim M.B., Banerjee D.K., Kelner K., Offutt L., and Pollard H.B. Steroid regulation of monoamine oxidase activity in the adrenal medulla. FASEB J 3 (1989) 1753-1759